Welcome to the 546th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.
The highlights of this week's edition are a randomised controlled trial investigating a liberal approach to glucose control in critically ill patients with type 2 diabetes & the long-term outcomes of the VAM-IHCA trial; systematic reviews and meta analyses on probiotics in critical illness & ECMO during the first 2 years of the COVID-19 pandemic; and observational studies on one-year outcomes of mechanically ventilated COVID-19 ICU survivors & lung microbiota of critically ill COVID-19 patients.
There are also narrative reviews on temperature management and its role in cardiac arrest patients & precision medicine in ARDS; editorials on predicting the quality of survival after critical illness & cardiac surgery-associated acute kidney injury; commentaries on catheter dressings & the beginning of the end or the end of the beginning of COVID-19; as well as correspondence on the ethical justifications for time-limited trial of intensive care & the role of tranexamic acid in trauma.
If you only have time to read one review article this week, try this one on blood transfusion reactions.
There are just two weeks to CCR22, where we host:
Our social programme is packed too, with a run or yoga/pilates class both Thursday and Friday mornings, and social events Wednesday, Thursday and Friday nights.
The meeting is approved for 18 CPD points by the Royal College of Anaesthetists, with attendance available in-person (1 day, 2 day and 3 day options), virtually with CPD/CME points (paid) or virtually without CPD/CME points (free).
Registration for CCR22, on June 15th to 17th at Titanic Belfast, is open.